Dr. Reddy's Laboratories Ltd. Share Price Today: Live Updates & Key Insights

Dr. Reddy's Laboratories Ltd. share price today is $13.76, up -2.69%. The stock opened at $14.11 against the previous close of $14.14, with an intraday high of $14.13 and low of $13.75.

Dr. Reddy's Laboratories Ltd. Share Price Chart

Dr. Reddy's Laboratories Ltd.

us-stock
To Invest in {{usstockname}}
us-stock

Dr. Reddy's Laboratories Ltd. Share Price Performance

$13.76 -0.0269(-2.69%) RDY at 23 Mar 2026 02:59 PM Drug Manufacturers - Specialty & Generic
Lowest Today 13.75
Highest Today 14.13
Today’s Open 14.11
Prev. Close 14.14
52 Week High 16.07
52 Week Low 12.18
Day’s Range: Low 13.75 High 14.13
52-Week Range: Low 12.18 High 16.07
1 day return -
1 Week return -2.06
1 month return -6.39
3 month return -3.6
6 month return -5.72
1 year return +0.25
3 year return -74.72
5 year return -77.09
10 year return -

Dr. Reddy's Laboratories Ltd. Institutional Holdings

Robeco Institutional Asset Management BV 1.58

JPMorgan Chase & Co 1.45

BlackRock Inc 1.34

Royal Bank of Canada 1.22

Renaissance Technologies Corp 0.99

Aikya Investment Management Ltd 0.88

Morgan Stanley - Brokerage Accounts 0.76

RBC Emerging Markets Equity 0.67

RBC Emerging Markets Equity Fund F 0.67

Dimensional Fund Advisors, Inc. 0.64

Vanguard Group Inc 0.60

State Street Corp 0.50

BNP Paribas Arbitrage, SA 0.50

Robeco QI EM Active Equities I € 0.29

Robeco QI Emerging Cnsrv Eqs I € 0.26

Acadian Asset Management LLC 0.24

Vanguard Emerging Mkts Stock Idx Inv 0.23

Vanguard Global Minimum Volatility Admr 0.20

Avantis Emerging Markets Equity ETF 0.19

State Street® SPDR® Portfolio EM ETF 0.18

Bessemer Group Inc 0.17

American Century Companies Inc 0.16

DFA Emerging Markets Core Equity 2 I 0.16

UBS Group AG 0.15

Lazard Asset Management LLC 0.14

Creative Planning Inc 0.14

Northern Trust Corp 0.13

JPM Emerging Mkts Opps A (acc) USD 0.11

JPM GEM Opportunities-Composite 0.11

Vanguard Total Intl Stock Index Inv 0.11

The Goldman Sachs Group Inc 0.08

Caisse De Depot Et Placement Du Quebec 0.08

Dimensional EM LrgCap Core Eq ZUSDInsAcc 0.07

DFA Emerging Markets I 0.06

SEI Emerging Markets Equity F (SIT) 0.06

RBC Emerging Markets ex China Equity 0.06

RBC Emerging Markets exChina Equity Fd O 0.06

PrivilEdge Robeco EM Bt Enh USD X1 MA 0.06

RAM (Lux) Sys Emg Mkts Equities B USD 0.06

Robeco QI Customized EM Enh Idx Eqs 0.05

Dr. Reddy's Laboratories Ltd. Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 1

Dr. Reddy's Laboratories Ltd. Fundamentals

Market Cap 11456.45 M

PB Ratio 2.8692

PE Ratio 18.8493

Enterprise Value 11437.54 M

Total Assets 492989.00 M

Volume 4047384

Dr. Reddy's Laboratories Ltd. Company Financials

Annual Revenue FY25:325535000000 325535.0M, FY24:279164000000 279164.0M, FY23:245879000000 245879.0M, FY22:214391000000 214391.0M, FY21:189722000000 189722.0M

Annual Profit FY25:190428000000 190428.0M, FY24:163607000000 163607.0M, FY23:202972000000 202972.0M, FY22:113840000000 113840.0M, FY21:103077000000 103077.0M

Annual Net worth FY25:56544000000 56544.0M, FY24:55684000000 55684.0M, FY23:45073000000 45073.0M, FY22:23568000000 23568.0M, FY21:19149000000 19149.0M

Quarterly Revenue Q4/2025:87268000000 87268.0M, Q3/2025:88051000000 88051.0M, Q2/2025:85452000000 85452.0M, Q1/2025:85060000000 85060.0M, Q4/2024:83586000000 83586.0M

Quarterly Profit Q4/2025:46806000000 46806.0M, Q3/2025:48140000000 48140.0M, Q2/2025:48627000000 48627.0M, Q1/2025:47263000000 47263.0M, Q4/2024:49052000000 49052.0M

Quarterly Net worth Q4/2025:12098000000 12098.0M, Q3/2025:14372000000 14372.0M, Q2/2025:14178000000 14178.0M, Q1/2025:15938000000 15938.0M, Q4/2024:14133000000 14133.0M

About Dr. Reddy's Laboratories Ltd. & investment objective

Company Information Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Organisation Drug Manufacturers - Specialty & Generic

Employees 27811

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Motupalli Venkata Ramana M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Dr. Reddy's Laboratories Ltd. FAQs

What is the share price of Dr. Reddy's Laboratories Ltd. today?

The current share price of Dr. Reddy's Laboratories Ltd. is $13.76.

Can I buy Dr. Reddy's Laboratories Ltd. shares in India?

Yes, Indian investors can buy Dr. Reddy's Laboratories Ltd. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Dr. Reddy's Laboratories Ltd. shares in India?

You can easily invest in Dr. Reddy's Laboratories Ltd. shares from India by:

Can I buy fractional shares of Dr. Reddy's Laboratories Ltd.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Dr. Reddy's Laboratories Ltd.?

Dr. Reddy's Laboratories Ltd. has a market cap of $11456.45 M.

In which sector does Dr. Reddy's Laboratories Ltd. belong?

Dr. Reddy's Laboratories Ltd. operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Dr. Reddy's Laboratories Ltd. stocks?

To invest, you typically need:

What is the PE and PB ratio of Dr. Reddy's Laboratories Ltd.?

The PE ratio of Dr. Reddy's Laboratories Ltd. is 18.85 and the PB ratio is 2.87.